IBIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
IBIO, INC. (IBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.71 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-28
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-12-31 was 0.00 shares.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-09-30 was 0.00 shares.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was -474.31K shares.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-30 was -29.00K shares, a 441.18% decline year-over-year.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 1.71M shares, a 151.11% increase from fiscal 2025.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 679.80K shares.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 307.86K shares, a 1.82% decline from fiscal 2022.
- IBIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 313.57K shares, a 49.60% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 24 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.71M shares 10-K · filed 2026-08-28 | ||||||
| 2025-06-30 | 679.80K shares 10-K · filed 2026-08-28 | ||||||
| 2023-06-30 | 307.86K shares 10-K · filed 2023-09-27 | ||||||
| 2022-06-30 | 313.57K shares 10-K · filed 2023-09-27 | ||||||
| 2021-06-30 | 209.60K shares 10-K · filed 2022-10-11 | 5.24M shares 10-K · filed 2021-09-28 | |||||
| 2020-06-30 | 2.38M shares 10-K · filed 2021-09-28 | ||||||
| 2019-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | 0.00 shares 10-Q · filed 2020-02-14 | -474.31K shares derived: sum of 3 quarters · filed 2020-02-14 | ||||
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-14 | -474.31K shares derived: sum of 2 quarters · filed 2019-11-14 | |||||
| 2019-06-30 | -474.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | 400.00K shares 10-K · filed 2019-08-26 | 400.00K shares 10-K · filed 2020-10-13 | ||||
| 2019-03-31 | 874.31K shares 10-Q · filed 2019-05-10 | ||||||
| 2018-06-30 | -29.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | -29.00K shares derived: sum of 2 quarters · filed 2019-08-26 | -29.00K shares derived: sum of 3 quarters · filed 2019-08-26 | 21.00K shares 10-K · filed 2019-08-26 | |||
| 2018-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2018-05-11 | 50.00K shares 10-Q · filed 2018-05-11 | 58.50K shares derived: sum of 4 quarters · filed 2018-09-18 | |||
| 2017-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | 50.00K shares 10-Q · filed 2018-02-14 | 58.50K shares derived: sum of 3 quarters · filed 2018-09-18 | 208.50K shares derived: sum of 4 quarters · filed 2018-09-18 | |||
| 2017-09-30 | 50.00K shares 10-Q · filed 2017-11-09 | 58.50K shares derived: sum of 2 quarters · filed 2018-09-18 | 208.50K shares derived: sum of 3 quarters · filed 2018-09-18 | 208.50K shares derived: sum of 4 quarters · filed 2018-09-18 | |||
| 2017-06-30 | 8.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18 | 158.50K shares derived: sum of 2 quarters · filed 2018-09-18 | 158.50K shares derived: sum of 3 quarters · filed 2018-09-18 | 158.50K shares 10-K · filed 2018-09-18 | 1.58M shares 10-K · filed 2017-09-15 | ||
| 2017-03-31 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | 150.00K shares derived: sum of 2 quarters · filed 2017-05-15 | 150.00K shares 10-Q · filed 2017-05-15 | 150.00K shares derived: sum of 4 quarters · filed 2017-09-15 | |||
| 2017-03-01 | 15.00K shares 10-K · filed 2018-09-18 | ||||||
| 2016-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-21 | 0.00 shares 10-Q · filed 2017-02-21 | 0.00 shares derived: sum of 3 quarters · filed 2017-09-15 | 200.00K shares derived: sum of 4 quarters · filed 2017-09-15 | |||
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-18 | 0.00 shares derived: sum of 2 quarters · filed 2017-09-15 | 200.00K shares derived: sum of 3 quarters · filed 2017-09-15 | 200.00K shares derived: sum of 4 quarters · filed 2017-09-15 | |||
| 2016-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-15 | 200.00K shares derived: sum of 2 quarters · filed 2017-09-15 | 200.00K shares derived: sum of 3 quarters · filed 2017-09-15 | 2.75M shares 10-K · filed 2017-09-15 | |||
| 2016-03-31 | 200.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | 200.00K shares derived: sum of 2 quarters · filed 2016-05-23 | 2.75M shares 10-Q · filed 2016-05-23 | 2.75M shares derived: sum of 4 quarters · filed 2016-10-13 | |||
| 2015-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-22 | 2.55M shares 10-Q · filed 2016-02-22 | 2.55M shares derived: sum of 3 quarters · filed 2016-10-13 | 2.55M shares derived: sum of 4 quarters · filed 2016-10-13 | |||
| 2015-09-30 | 2.55M shares 10-Q · filed 2015-11-13 | 2.55M shares derived: sum of 2 quarters · filed 2016-10-13 | 2.55M shares derived: sum of 3 quarters · filed 2016-10-13 | 2.65M shares derived: sum of 4 quarters · filed 2016-10-13 | |||
| 2015-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | 0.00 shares derived: sum of 2 quarters · filed 2016-10-13 | 100.00K shares derived: sum of 3 quarters · filed 2016-10-13 | 1.74M shares 10-K · filed 2016-10-13 | |||
| 2015-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | 100.00K shares derived: sum of 2 quarters · filed 2015-05-15 | 1.74M shares 10-Q · filed 2015-05-15 | -1.99B shares derived: sum of 4 quarters · filed 2015-10-13 | |||
| 2014-12-31 | 100.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-24 | 1.74M shares 10-Q · filed 2015-02-24 | -1.99B shares derived: sum of 3 quarters · filed 2015-10-13 | 1.84M shares derived: sum of 4 quarters · filed 2015-10-13 | |||
| 2014-09-30 | 1.64M shares 10-Q · filed 2014-11-14 | -1.99B shares derived: sum of 2 quarters · filed 2015-10-13 | 1.74M shares derived: sum of 3 quarters · filed 2015-10-13 | 2.34M shares derived: sum of 4 quarters · filed 2015-10-13 | |||
| 2014-06-30 | -1.99B shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | 100.00K shares derived: sum of 2 quarters · filed 2015-10-13 | 700.00K shares derived: sum of 3 quarters · filed 2015-10-13 | 1.99M shares 10-K · filed 2015-10-13 | |||
| 2014-03-31 | 1.99B shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | 1.99B shares derived: sum of 2 quarters · filed 2014-05-15 | 1.99B shares 10-Q · filed 2014-05-15 | 1.99B shares derived: sum of 4 quarters · filed 2014-09-29 | |||
| 2013-12-31 | 600.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | 1.89M shares 10-Q · filed 2014-02-14 | 1.89M shares derived: sum of 3 quarters · filed 2014-09-29 | 1.99M shares derived: sum of 4 quarters · filed 2014-09-29 | |||
| 2013-09-30 | 1.29M shares 10-Q · filed 2013-11-14 | 1.29M shares derived: sum of 2 quarters · filed 2014-09-29 | 1.39M shares derived: sum of 3 quarters · filed 2014-09-29 | 1.55M shares derived: sum of 4 quarters · filed 2014-09-29 | |||
| 2013-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | 100.00K shares derived: sum of 2 quarters · filed 2014-09-29 | 260.00K shares derived: sum of 3 quarters · filed 2014-09-29 | 1.33M shares 10-K · filed 2014-09-29 | |||
| 2013-03-31 | 100.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-20 | 260.00K shares derived: sum of 2 quarters · filed 2013-05-20 | 1.33M shares 10-Q · filed 2013-05-20 | ||||
| 2012-12-31 | 160.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-19 | 1.23M shares 10-Q · filed 2013-02-19 | |||||
| 2012-09-30 | 1.07M shares 10-Q · filed 2012-11-14 | ||||||
| 2012-06-30 | 1.16M shares 10-K/A · filed 2012-10-15 | ||||||
| 2011-06-30 | 2.14M shares 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |